Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 9 of 9 entries
Sorted by: Best Match Show Resources per page
Current role of interventional radiology in the management of visceral and bone metastases from thyroid cancer.

Gland surgery

Cazzato RL, Garnon J, Koch G, Shaygi B, Tsoumakidou G, Caudrelier J, Boatta E, Buy X, Palussiere J, Gangi A.
PMID: 29770304
Gland Surg. 2018 Apr;7(2):80-88. doi: 10.21037/gs.2017.12.08.

The metastatic disease from thyroid cancer represents a complex clinical scenario, which mandates a case-based multi-disciplinary approach in tertiary referral centers. Direct localised treatments such as minimally invasive interventional radiology procedures can play a vital role in providing a...

Cite
Cazzato RL, Garnon J, Koch G, et al. Current role of interventional radiology in the management of visceral and bone metastases from thyroid cancer. Gland Surg. 2018;7(2):80-88doi: 10.21037/gs.2017.12.08.
Cazzato, R. L., Garnon, J., Koch, G., Shaygi, B., Tsoumakidou, G., Caudrelier, J., Boatta, E., Buy, X., Palussiere, J., & Gangi, A. (2018). Current role of interventional radiology in the management of visceral and bone metastases from thyroid cancer. Gland surgery, 7(2), 80-88. https://doi.org/10.21037/gs.2017.12.08
Cazzato, Roberto Luigi, et al. "Current role of interventional radiology in the management of visceral and bone metastases from thyroid cancer." Gland surgery vol. 7,2 (2018): 80-88. doi: https://doi.org/10.21037/gs.2017.12.08
Cazzato RL, Garnon J, Koch G, Shaygi B, Tsoumakidou G, Caudrelier J, Boatta E, Buy X, Palussiere J, Gangi A. Current role of interventional radiology in the management of visceral and bone metastases from thyroid cancer. Gland Surg. 2018 Apr;7(2):80-88. doi: 10.21037/gs.2017.12.08. PMID: 29770304; PMCID: PMC5938279.
Copy Download .nbib Format: NLM
Lung tumor MHCII immunity depends on in situ antigen presentation by fibroblasts.

The Journal of experimental medicine

Kerdidani D, Aerakis E, Verrou KM, Angelidis I, Douka K, Maniou MA, Stamoulis P, Goudevenou K, Prados A, Tzaferis C, Ntafis V, Vamvakaris I, Kaniaris E, Vachlas K, Sepsas E, Koutsopoulos A, Potaris K, Tsoumakidou M.
PMID: 35029648
J Exp Med. 2022 Feb 07;219(2). doi: 10.1084/jem.20210815. Epub 2022 Jan 14.

A key unknown of the functional space in tumor immunity is whether CD4 T cells depend on intratumoral MHCII cancer antigen recognition. MHCII-expressing, antigen-presenting cancer-associated fibroblasts (apCAFs) have been found in breast and pancreatic tumors and are considered to...

Cite
Kerdidani D, Aerakis E, Verrou KM, et al. Lung tumor MHCII immunity depends on in situ antigen presentation by fibroblasts. J Exp Med. 2022;219(2)doi: 10.1084/jem.20210815.
Kerdidani, D., Aerakis, E., Verrou, K. M., Angelidis, I., Douka, K., Maniou, M. A., Stamoulis, P., Goudevenou, K., Prados, A., Tzaferis, C., Ntafis, V., Vamvakaris, I., Kaniaris, E., Vachlas, K., Sepsas, E., Koutsopoulos, A., Potaris, K., & Tsoumakidou, M. (2022). Lung tumor MHCII immunity depends on in situ antigen presentation by fibroblasts. The Journal of experimental medicine, 219(2), . https://doi.org/10.1084/jem.20210815
Kerdidani, Dimitra, et al. "Lung tumor MHCII immunity depends on in situ antigen presentation by fibroblasts." The Journal of experimental medicine vol. 219,2 (2022). doi: https://doi.org/10.1084/jem.20210815
Kerdidani D, Aerakis E, Verrou KM, Angelidis I, Douka K, Maniou MA, Stamoulis P, Goudevenou K, Prados A, Tzaferis C, Ntafis V, Vamvakaris I, Kaniaris E, Vachlas K, Sepsas E, Koutsopoulos A, Potaris K, Tsoumakidou M. Lung tumor MHCII immunity depends on in situ antigen presentation by fibroblasts. J Exp Med. 2022 Feb 07;219(2). doi: 10.1084/jem.20210815. Epub 2022 Jan 14. PMID: 35029648.
Copy Download .nbib Format: NLM
Cryoablation of Extra-Abdominal Desmoid Tumors: A Single-Center Experience with Literature Review.

Diagnostics (Basel, Switzerland)

Saltiel S, Bize PE, Goetti P, Gallusser N, Cherix S, Denys A, Becce F, Tsoumakidou G.
PMID: 32759783
Diagnostics (Basel). 2020 Aug 04;10(8). doi: 10.3390/diagnostics10080556.

Cryoablation (CA) has gained popularity in the treatment of benign and malignant musculoskeletal tumors. While extra-abdominal desmoid (EAD) tumors are not malignant, they remain challenging to treat because of their high local recurrence rate. We reviewed all EAD tumors...

Cite
Saltiel S, Bize PE, Goetti P, et al. Cryoablation of Extra-Abdominal Desmoid Tumors: A Single-Center Experience with Literature Review. Diagnostics (Basel). 2020;10(8)doi: 10.3390/diagnostics10080556.
Saltiel, S., Bize, P. E., Goetti, P., Gallusser, N., Cherix, S., Denys, A., Becce, F., & Tsoumakidou, G. (2020). Cryoablation of Extra-Abdominal Desmoid Tumors: A Single-Center Experience with Literature Review. Diagnostics (Basel, Switzerland), 10(8), . https://doi.org/10.3390/diagnostics10080556
Saltiel, Sarah, et al. "Cryoablation of Extra-Abdominal Desmoid Tumors: A Single-Center Experience with Literature Review." Diagnostics (Basel, Switzerland) vol. 10,8 (2020). doi: https://doi.org/10.3390/diagnostics10080556
Saltiel S, Bize PE, Goetti P, Gallusser N, Cherix S, Denys A, Becce F, Tsoumakidou G. Cryoablation of Extra-Abdominal Desmoid Tumors: A Single-Center Experience with Literature Review. Diagnostics (Basel). 2020 Aug 04;10(8). doi: 10.3390/diagnostics10080556. PMID: 32759783; PMCID: PMC7460498.
Copy Download .nbib Format: NLM
Radiofrequency Ablation to Control Bleeding from a Percutaneous Intrahepatic Puncture Tract of a Large Diameter Portal Vein: A Simple and Rapid Solution to a Potentially Life-Threatening Bleeding.

Cardiovascular and interventional radiology

Vermersch M, Duran R, Vietti Violi N, Villard N, Tsoumakidou G, Denys A, Hocquelet A.
PMID: 32728797
Cardiovasc Intervent Radiol. 2020 Nov;43(11):1725-1727. doi: 10.1007/s00270-020-02598-z. Epub 2020 Jul 29.

No abstract available.

Cite
Vermersch M, Duran R, Vietti Violi N, et al. Radiofrequency Ablation to Control Bleeding from a Percutaneous Intrahepatic Puncture Tract of a Large Diameter Portal Vein: A Simple and Rapid Solution to a Potentially Life-Threatening Bleeding. Cardiovasc Intervent Radiol. 2020;43(11):1725-1727doi: 10.1007/s00270-020-02598-z.
Vermersch, M., Duran, R., Vietti Violi, N., Villard, N., Tsoumakidou, G., Denys, A., & Hocquelet, A. (2020). Radiofrequency Ablation to Control Bleeding from a Percutaneous Intrahepatic Puncture Tract of a Large Diameter Portal Vein: A Simple and Rapid Solution to a Potentially Life-Threatening Bleeding. Cardiovascular and interventional radiology, 43(11), 1725-1727. https://doi.org/10.1007/s00270-020-02598-z
Vermersch, Mathilde, et al. "Radiofrequency Ablation to Control Bleeding from a Percutaneous Intrahepatic Puncture Tract of a Large Diameter Portal Vein: A Simple and Rapid Solution to a Potentially Life-Threatening Bleeding." Cardiovascular and interventional radiology vol. 43,11 (2020): 1725-1727. doi: https://doi.org/10.1007/s00270-020-02598-z
Vermersch M, Duran R, Vietti Violi N, Villard N, Tsoumakidou G, Denys A, Hocquelet A. Radiofrequency Ablation to Control Bleeding from a Percutaneous Intrahepatic Puncture Tract of a Large Diameter Portal Vein: A Simple and Rapid Solution to a Potentially Life-Threatening Bleeding. Cardiovasc Intervent Radiol. 2020 Nov;43(11):1725-1727. doi: 10.1007/s00270-020-02598-z. Epub 2020 Jul 29. PMID: 32728797.
Copy Download .nbib Format: NLM
Emphysema assessment for personalized immunotherapy response prediction in lung cancer patients.

Journal of thoracic disease

Kerdidani D, Magkouta S, Tsoumakidou M.
PMID: 31632820
J Thorac Dis. 2019 Sep;11:S2034-S2035. doi: 10.21037/jtd.2019.08.98.

No abstract available.

Cite
Kerdidani D, Magkouta S, Tsoumakidou M. Emphysema assessment for personalized immunotherapy response prediction in lung cancer patients. J Thorac Dis. 2019;11:S2034-S2035doi: 10.21037/jtd.2019.08.98.
Kerdidani, D., Magkouta, S., & Tsoumakidou, M. (2019). Emphysema assessment for personalized immunotherapy response prediction in lung cancer patients. Journal of thoracic disease, 11S2034-S2035. https://doi.org/10.21037/jtd.2019.08.98
Kerdidani, Dimitra, et al. "Emphysema assessment for personalized immunotherapy response prediction in lung cancer patients." Journal of thoracic disease vol. 11 (2019): S2034-S2035. doi: https://doi.org/10.21037/jtd.2019.08.98
Kerdidani D, Magkouta S, Tsoumakidou M. Emphysema assessment for personalized immunotherapy response prediction in lung cancer patients. J Thorac Dis. 2019 Sep;11:S2034-S2035. doi: 10.21037/jtd.2019.08.98. PMID: 31632820; PMCID: PMC6783793.
Copy Download .nbib Format: NLM
Lung tumor MHCII immunity depends on in situ antigen presentation by fibroblasts.

The Journal of experimental medicine

Kerdidani D, Aerakis E, Verrou KM, Angelidis I, Douka K, Maniou MA, Stamoulis P, Goudevenou K, Prados A, Tzaferis C, Ntafis V, Vamvakaris I, Kaniaris E, Vachlas K, Sepsas E, Koutsopoulos A, Potaris K, Tsoumakidou M.
PMID: 35029648
J Exp Med. 2022 Feb 07;219(2). doi: 10.1084/jem.20210815. Epub 2022 Jan 14.

A key unknown of the functional space in tumor immunity is whether CD4 T cells depend on intratumoral MHCII cancer antigen recognition. MHCII-expressing, antigen-presenting cancer-associated fibroblasts (apCAFs) have been found in breast and pancreatic tumors and are considered to...

Cite
Kerdidani D, Aerakis E, Verrou KM, et al. Lung tumor MHCII immunity depends on in situ antigen presentation by fibroblasts. J Exp Med. 2022;219(2)doi: 10.1084/jem.20210815.
Kerdidani, D., Aerakis, E., Verrou, K. M., Angelidis, I., Douka, K., Maniou, M. A., Stamoulis, P., Goudevenou, K., Prados, A., Tzaferis, C., Ntafis, V., Vamvakaris, I., Kaniaris, E., Vachlas, K., Sepsas, E., Koutsopoulos, A., Potaris, K., & Tsoumakidou, M. (2022). Lung tumor MHCII immunity depends on in situ antigen presentation by fibroblasts. The Journal of experimental medicine, 219(2), . https://doi.org/10.1084/jem.20210815
Kerdidani, Dimitra, et al. "Lung tumor MHCII immunity depends on in situ antigen presentation by fibroblasts." The Journal of experimental medicine vol. 219,2 (2022). doi: https://doi.org/10.1084/jem.20210815
Kerdidani D, Aerakis E, Verrou KM, Angelidis I, Douka K, Maniou MA, Stamoulis P, Goudevenou K, Prados A, Tzaferis C, Ntafis V, Vamvakaris I, Kaniaris E, Vachlas K, Sepsas E, Koutsopoulos A, Potaris K, Tsoumakidou M. Lung tumor MHCII immunity depends on in situ antigen presentation by fibroblasts. J Exp Med. 2022 Feb 07;219(2). doi: 10.1084/jem.20210815. Epub 2022 Jan 14. PMID: 35029648.
Copy Download .nbib Format: NLM
Correction to: CIRSE Clinical Practice Manual.

Cardiovascular and interventional radiology

Mahnken AH, Seoane EB, Cannavale A, de Haan MW, Dezman R, Kloeckner R, O'Sullivan G, Ryan A, Tsoumakidou G.
PMID: 34296339
Cardiovasc Intervent Radiol. 2021 Sep;44(9):1498. doi: 10.1007/s00270-021-02927-w.

No abstract available.

Cite
Mahnken AH, Seoane EB, Cannavale A, et al. Correction to: CIRSE Clinical Practice Manual. Cardiovasc Intervent Radiol. 2021;44(9):1498doi: 10.1007/s00270-021-02927-w.
Mahnken, A. H., Seoane, E. B., Cannavale, A., de Haan, M. W., Dezman, R., Kloeckner, R., O'Sullivan, G., Ryan, A., & Tsoumakidou, G. (2021). Correction to: CIRSE Clinical Practice Manual. Cardiovascular and interventional radiology, 44(9), 1498. https://doi.org/10.1007/s00270-021-02927-w
Mahnken, Andreas H, et al. "Correction to: CIRSE Clinical Practice Manual." Cardiovascular and interventional radiology vol. 44,9 (2021): 1498. doi: https://doi.org/10.1007/s00270-021-02927-w
Mahnken AH, Seoane EB, Cannavale A, de Haan MW, Dezman R, Kloeckner R, O'Sullivan G, Ryan A, Tsoumakidou G. Correction to: CIRSE Clinical Practice Manual. Cardiovasc Intervent Radiol. 2021 Sep;44(9):1498. doi: 10.1007/s00270-021-02927-w. PMID: 34296339; PMCID: PMC8587268.
Copy Download .nbib Format: NLM
Image-guided marking techniques in interventional radiology: A review of current evidence.

Diagnostic and interventional imaging

Tsoumakidou G, Saltiel S, Villard N, Duran R, Meuwly JY, Denys A.
PMID: 34419388
Diagn Interv Imaging. 2021 Dec;102(12):699-707. doi: 10.1016/j.diii.2021.07.002. Epub 2021 Aug 18.

Precise marking of lesions using image-guided techniques is essential, as imprecise targeting of a tumor can result in either insufficient excision/treatment with an increased risk of recurrence, or excessive removal of healthy tissue. Most frequent indications include localization of...

Cite
Tsoumakidou G, Saltiel S, Villard N, et al. Image-guided marking techniques in interventional radiology: A review of current evidence. Diagn Interv Imaging. 2021;102(12):699-707doi: 10.1016/j.diii.2021.07.002.
Tsoumakidou, G., Saltiel, S., Villard, N., Duran, R., Meuwly, J. Y., & Denys, A. (2021). Image-guided marking techniques in interventional radiology: A review of current evidence. Diagnostic and interventional imaging, 102(12), 699-707. https://doi.org/10.1016/j.diii.2021.07.002
Tsoumakidou, Georgia, et al. "Image-guided marking techniques in interventional radiology: A review of current evidence." Diagnostic and interventional imaging vol. 102,12 (2021): 699-707. doi: https://doi.org/10.1016/j.diii.2021.07.002
Tsoumakidou G, Saltiel S, Villard N, Duran R, Meuwly JY, Denys A. Image-guided marking techniques in interventional radiology: A review of current evidence. Diagn Interv Imaging. 2021 Dec;102(12):699-707. doi: 10.1016/j.diii.2021.07.002. Epub 2021 Aug 18. PMID: 34419388.
Copy Download .nbib Format: NLM
Image-guided marking techniques in interventional radiology: A review of current evidence.

Diagnostic and interventional imaging

Tsoumakidou G, Saltiel S, Villard N, Duran R, Meuwly JY, Denys A.
PMID: 34419388
Diagn Interv Imaging. 2021 Dec;102(12):699-707. doi: 10.1016/j.diii.2021.07.002. Epub 2021 Aug 18.

Precise marking of lesions using image-guided techniques is essential, as imprecise targeting of a tumor can result in either insufficient excision/treatment with an increased risk of recurrence, or excessive removal of healthy tissue. Most frequent indications include localization of...

Cite
Tsoumakidou G, Saltiel S, Villard N, et al. Image-guided marking techniques in interventional radiology: A review of current evidence. Diagn Interv Imaging. 2021;102(12):699-707doi: 10.1016/j.diii.2021.07.002.
Tsoumakidou, G., Saltiel, S., Villard, N., Duran, R., Meuwly, J. Y., & Denys, A. (2021). Image-guided marking techniques in interventional radiology: A review of current evidence. Diagnostic and interventional imaging, 102(12), 699-707. https://doi.org/10.1016/j.diii.2021.07.002
Tsoumakidou, Georgia, et al. "Image-guided marking techniques in interventional radiology: A review of current evidence." Diagnostic and interventional imaging vol. 102,12 (2021): 699-707. doi: https://doi.org/10.1016/j.diii.2021.07.002
Tsoumakidou G, Saltiel S, Villard N, Duran R, Meuwly JY, Denys A. Image-guided marking techniques in interventional radiology: A review of current evidence. Diagn Interv Imaging. 2021 Dec;102(12):699-707. doi: 10.1016/j.diii.2021.07.002. Epub 2021 Aug 18. PMID: 34419388.
Copy Download .nbib Format: NLM
Showing 1 to 9 of 9 entries